Pericytes in Tumor Vessels
- 1Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, 70124 Bari, Italy
- 2Nuffield Division of Laboratory Science, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
Abstract
Pericytes are specialized mural cells that closely interact with endothelial cells to regulate vascular development, stability, and homeostasis through signaling pathways including PDGF-B/PDGFR-β, TGF-β, Angiopoietin-1/Tie2, and N-cadherin. In cancer, they display remarkable phenotypic and functional plasticity, becoming key regulators of tumor angiogenesis and the tumor microenvironment. Disrupted pericyte–endothelial interactions contribute to the formation of abnormal, highly permeable blood vessels, promoting hypoxia, tumor progression, immune evasion, and metastasis. Beyond their vascular role, pericytes actively communicate with tumor-associated macrophages, cancer-associated fibroblasts, and extracellular matrix components, thereby influencing epithelial-to-mesenchymal transition, pre-metastatic niche formation, and therapeutic resistance. Increasing evidence also suggests that pericytes undergo phenotypic transitions that further support tumor progression. Conversely, restoring pericyte function and promoting vessel normalization have emerged as promising strategies to improve vascular integrity, tissue oxygenation, drug delivery, and the efficacy of anti-angiogenic therapies and immunotherapy. Preclinical and early clinical studies indicate that targeting pathways regulating pericyte recruitment and function, particularly in combination with endothelial-directed therapies, may produce synergistic anti-tumor effects. This review highlights the multifaceted roles of pericytes in tumor vascular remodeling, immune regulation, metastasis, and their potential as therapeutic targets in cancer.
Related
- Senescence and tumor immunology: A multifaceted interplay of influence
- Exercise oncology and tumor sterol metabolism: An emerging mechanistic frontier
- Editorial: Unlocking the potential of extracellular vesicles in tumor immunity and drug resistance
- Label-free morphometric profiling reveals early drug responses in 3D tumor spheroids
- Exploratory analysis of Notch and Wnt pathway gene expression across biofluids and tumor tissue in gynecologic cancer
BibTeX
@article{ribatti2026pericytes,
title = {{Pericytes in Tumor Vessels}},
author = {Domenico Ribatti and Roberto Tamma and Francesco Pezzella},
journal = {Cells},
year = {2026},
month = oct,
doi = {10.3390/cells15201867},
url = {https://www.mdpi.com/2073-4409/15/20/1867},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pericytes in Tumor Vessels
AU - Domenico Ribatti
AU - Roberto Tamma
AU - Francesco Pezzella
PY - 2026
DA - 2026/10/14
JO - Cells
DO - 10.3390/cells15201867
UR - https://www.mdpi.com/2073-4409/15/20/1867
AB - Pericytes are specialized mural cells that closely interact with endothelial cells to regulate vascular development, stability, and homeostasis through signaling pathways including PDGF-B/PDGFR-β, TGF-β, Angiopoietin-1/Tie2, and N-cadherin. In cancer, they display remarkable phenotypic and functional plasticity, becoming key regulators of tumor angiogenesis and the tumor microenvironment. Disrupted pericyte–endothelial interactions contribute to the formation of abnormal, highly permeable blood vessels, promoting hypoxia, tumor progression, immune evasion, and metastasis. Beyond their vascular role, pericytes actively communicate with tumor-associated macrophages, cancer-associated fibroblasts, and extracellular matrix components, thereby influencing epithelial-to-mesenchymal transition, pre-metastatic niche formation, and therapeutic resistance. Increasing evidence also suggests that pericytes undergo phenotypic transitions that further support tumor progression. Conversely, restoring pericyte function and promoting vessel normalization have emerged as promising strategies to improve vascular integrity, tissue oxygenation, drug delivery, and the efficacy of anti-angiogenic therapies and immunotherapy. Preclinical and early clinical studies indicate that targeting pathways regulating pericyte recruitment and function, particularly in combination with endothelial-directed therapies, may produce synergistic anti-tumor effects. This review highlights the multifaceted roles of pericytes in tumor vascular remodeling, immune regulation, metastasis, and their potential as therapeutic targets in cancer.
SN - 2073-4409
ER -